CARDIOGENOMIC TESTING ALLIANCE INC (EIN 873531345) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

TOM FAGLEY

Phone

2025771370

Tax Period

2025-01-01 to 2025-12-31

CARDIOGENOMIC TESTING ALLIANCE INC, founded in 2021, is a micro nonprofit in the Community Improvement sector that reported $60K in total revenue in fiscal year 2025. Revenue surged 500% from the prior year, signaling strong growth momentum.

Mission

THE CARDIOGENOMIC TESTING ALLIANCE (CGTA) AIMS TO RAISE AWARENESS AND UTILIZATION OF GENOMIC TESTING IN CARDIOLOGY. THE ALLIANCE SEEKS TO EDUCATE HEALTH CARE PROVIDERS AND OTHER STAKEHOLDERS ABOUT THE VALUE OF SUCH TESTING TO ASSURE ADHERENCE TO EXISTING GUIDELINES FROM PROFESSIONAL MEDICAL SOCIETIES, TO INFORM MEDICAL MANAGEMENT AND CASCADE TESTING, AND TO IMPROVE CLINICAL OUTCOMES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $60,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $60,000

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $48,735

Other Expenses $61,056

TOTAL EXPENSES $61,056

Year-over-Year Comparison

	2025	2024	Change
Revenue	$60,000	$10,000	+5.0%
Expenses	$61,056	$129,143	-0.5%
Net Income	$-1,056	$-119,143	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
HOLLY SNYDER	CHAIR	1.00	Officer Director	$0	$0	$0
KRISTEN LAFAYETTE	SECRETARY	1.00	Officer Director	$0	$0	$0
TOM FAGLEY	ASSISTANT TREASURER	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$60,000	$61,056	$7,916	$-1,056
2024	No data	No data	No data	No data
2023	$195,000	$147,957	$128,115	$47,043
2022	$240,000	$159,078	$81,072	$80,922

CARDIOGENOMIC TESTING ALLIANCE INC